PubRank

Preclinical development and ocular biodistribution of gemini-DNA nanoparticles after intravitreal and topical administration: towards non-invasive glaucoma gene therapy.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 24905400)

Published in Nanomedicine on June 04, 2014

Authors

Samih Alqawlaq1, Jeremy M Sivak2, J Torin Huzil1, Marina V Ivanova1, John G Flanagan3, Michael A Beazely1, Marianna Foldvari4

Author Affiliations

1: School of Pharmacy, University of Waterloo, Waterloo, ON, Canada.
2: Ophthalmology and Vision Science, University of Toronto, Toronto, ON, Canada; University Health Network, Division of Visual Science, Toronto Western Research Institute, Toronto Western Hospital, Toronto, ON, Canada.
3: School of Optometry, University of Waterloo, Waterloo, ON, Canada; Ophthalmology and Vision Science, University of Toronto, Toronto, ON, Canada; University Health Network, Division of Visual Science, Toronto Western Research Institute, Toronto Western Hospital, Toronto, ON, Canada.
4: School of Pharmacy, University of Waterloo, Waterloo, ON, Canada. Electronic address: foldvari@uwaterloo.ca.

Articles citing this ↘

A holistic approach to targeting disease with polymeric nanoparticles. Nat Rev Drug Discov (2015) 1.31

5-HT7 receptor activation promotes an increase in TrkB receptor expression and phosphorylation. Front Behav Neurosci (2014) 0.80

An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration. J Control Release (2017) 0.80

Recent Advances in Nanomaterials for Gene Delivery-A Review. Nanomaterials (Basel) (2017) 0.78

Non-viral therapeutic approaches to ocular diseases: An overview and future directions. J Control Release (2015) 0.78

Nanoparticle-motivated gene delivery for ophthalmic application. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2015) 0.76

Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure. Transl Vis Sci Technol (2015) 0.75

A flow cytometric approach to study the mechanism of gene delivery to cells by gemini-lipid nanoparticles: an implication for cell membrane nanoporation. J Nanobiotechnology (2015) 0.75

The intricacies of neurotrophic factor therapy for retinal ganglion cell rescue in glaucoma: a case for gene therapy. Neural Regen Res (2016) 0.75

Articles by these authors ⇆

Pharmaceutical characterization of solid and dispersed carbon nanotubes as nanoexcipients. Int J Nanomedicine (2012) 0.81